Study finds migraine and anxiety dominate in a third of endometriosis cases

Nearly one in three women with endometriosis experience migraine, anxiety or depression as the dominant feature of their illness rather than the pelvic pain traditionally associated with the condition, according to a new study published in the journal Human Reproduction.

The research, which analysed data from more than 22,000 women, identified four distinct symptom patterns among endometriosis patients. While severe menstrual cramps and abdominal pain severe enough to cause vomiting remain the most widely recognised signs of the disease, the study found that for a substantial share of patients these symptoms are not what defines their day-to-day experience of the illness.

Instead, researchers found that headaches, particularly migraine, along with mental health symptoms such as anxiety and depression, can become the leading complaints for close to a third of those studied. The findings suggest the disease, which begins in the pelvic region, can in many cases shift its centre of impact to the nervous system and mental wellbeing as it progresses.

Endometriosis occurs when tissue similar to the lining of the uterus grows outside the womb, often on the ovaries, fallopian tubes or other pelvic structures. It is a chronic condition that affects a significant proportion of women of reproductive age worldwide, though exact prevalence figures vary between countries and studies.

The classic presentation of the disease has long centred on pelvic pain, heavy or irregular bleeding, pain during intercourse and fertility difficulties. The new research adds to a growing body of evidence suggesting the condition's effects extend well beyond the reproductive organs, with knock-on consequences for the brain and mood.

By grouping patients according to which symptoms were most prominent, the study's authors were able to describe four separate clinical pictures of the disease. One of these clusters, representing roughly a third of the women studied, was characterised primarily by migraine alongside anxiety and depressive symptoms, rather than by the abdominal and pelvic pain usually linked to endometriosis.

Researchers said the scale of the study, covering more than 22,000 participants, allowed for a level of statistical confidence in identifying these patterns that smaller studies have not previously achieved. The size of the dataset also made it possible to separate patients into meaningful subgroups based on symptom severity and type, rather than treating endometriosis as a single uniform condition.

The findings carry implications for how doctors diagnose and manage the disease. Endometriosis is already notoriously difficult to identify, with many patients experiencing delays of several years between the onset of symptoms and a confirmed diagnosis. Specialists have long pointed to the variability of symptoms as one reason the condition is frequently missed or mistaken for other disorders.

If headaches, anxiety or depression are the most visible symptoms in a meaningful proportion of cases, doctors who are not specifically looking for gynaecological causes may be less likely to consider endometriosis as an underlying explanation. Patients presenting primarily with migraine or mood disturbances might instead be referred to neurologists or mental health specialists without the pelvic origin of their condition being investigated.

The study's authors argued that recognising these four symptom patterns could help clinicians across different specialities consider endometriosis earlier in the diagnostic process, potentially shortening the time it currently takes many women to receive an accurate diagnosis and appropriate treatment.

The research does not establish the precise biological mechanism linking endometriosis to migraine, anxiety and depression, though chronic pain conditions have previously been associated with changes in how the nervous system processes pain signals over time, as well as with elevated rates of mood disorders. Further research is expected to examine why the disease manifests so differently from patient to patient and what this means for tailoring treatment approaches to the specific symptom profile a woman experiences.

Endometriosis currently has no cure, and treatment options range from pain medication and hormonal therapy to surgery, depending on the severity and location of the tissue growth. Doctors typically adjust treatment plans according to a patient's symptoms, age and plans for future pregnancy.